OTIC Otonomy, Inc. gains 38% Jan 9, 2020

Otonomy, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for diseases and disorders of the ear in the United States. It offers OTIPRIO, a ciprofloxacin otic suspension for use during tympanostomy tube placement surgery in pediatric patients. OTIPRIO has also completed a Phase III clinical trial for treating swimmer's ear and a Phase II clinical trial for treating acute otitis media with tubes. The company also develops OTO-104, a sustained-exposure formulation of the steroid dexamethasone in Phase III clinical trial for the treatment of Meniere's disease and other inner ear conditions; and OTO-311, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which has completed a Phase 1 clinical safety trial for the treatment of tinnitus. Otonomy, Inc. was founded in 2008 and is headquartered in San Diego, California.http://www.priceseries.com/trade/OTIC-Otonomy-Inc-stock-gains-38-percent-a-Trade-Record-by-priceSeries-2019122320200109.html

MTDR Matador Resources Company gains 22% Jan 9, 2020

Matador Resources Company, an independent energy company, engages in the exploration, development, production, and acquisition of oil and natural gas resources in the United States. It operates in two segments, Exploration and Production, and Midstream. The company primarily holds interests in the Wolfcamp and Bone Spring plays in the Delaware Basin in Southeast New Mexico and West Texas; the Eagle Ford shale play in South Texas; and the Haynesville shale and Cotton Valley plays in Northwest Louisiana and East Texas. It also conducts midstream operations in support of the company's exploration, development, and production operations, as well as provides natural gas processing, natural gas, oil, and salt water gathering services; and salt water disposal services to third parties. As of December 31, 2016, its estimated proved oil and natural gas reserves were 105.8 million barrels of oil equivalent, including 57 million stock tank barrels of oil and 292.6 billion cubic feet of natural gas. The company was formerly known as Matador Holdco, Inc. and changed its name to Matador Resources Company in August 2011. Matador Resources Company was founded in 2003 and is headquartered in Dallas, Texas.http://www.priceseries.com/trade/MTDR-Matador-Resources-Company-stock-gains-22-percent-a-Trade-Record-by-priceSeries-2019120620200109.html

GVP GSE Systems, Inc. gains 42% Jan 9, 2020

GSE Systems, Inc. provides simulation, engineering, and training solutions and services to the nuclear and fossil power generation, oil and gas, refining, chemicals, petrochemicals, industrial gas, manufacturing, and plant utilities markets worldwide. It operates in two segments, Performance Improvement Solutions and Nuclear Industry Training and Consulting. The company offers instructors, procedure writers, work management specialists, planners, and training material developers. It also offers a software platform for online learning and learning management for the energy market. The company markets its products and services through a network of direct sales staff, agents and representatives, and strategic alliance partners. GSE Systems, Inc. was founded in 1994 and is headquartered in Sykesville, Maryland.http://www.priceseries.com/trade/GVP-GSE-Systems-Inc-stock-gains-42-percent-a-Trade-Record-by-priceSeries-2019121320200109.html

GTE Gran Tierra Energy Inc. gains 18% Jan 9, 2020

Gran Tierra Energy Inc., an independent energy company, engages in the acquisition, exploration, development, and production of oil and gas properties in Colombia, Peru, and Brazil. As of December 31, 2016, the company had total proved undeveloped reserves of 14.9 million barrels of oil equivalent (MMBOE), including 10.4 MMBOE in Colombia and 4.5 MMBOE in Brazil. Gran Tierra Energy Inc. was incorporated in 2003 and is headquartered in Calgary, Canada.http://www.priceseries.com/trade/GTE-Gran-Tierra-Energy-Inc-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2019120920200109.html

CPG Crescent Point Energy Corp. gains 16% Jan 9, 2020

Crescent Point Energy Corp. acquires, explores, develops, and produces light and medium oil and natural gas properties in Western Canada and the United States. The company's crude oil and natural gas properties, and related assets are located in the provinces of Saskatchewan, Alberta, British Columbia, and Manitoba; and the states of North Dakota, Montana, Colorado, and Utah. Crescent Point Energy Corp. is headquartered in Calgary, Canada.http://www.priceseries.com/trade/CPG-Crescent-Point-Energy-Corp-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2019121220200109.html

CAI CAI Intl., Inc. gains 18% Jan 9, 2020

CAI International, Inc. operates as transportation finance and logistics company in the United States and internationally. It leases, re-leases, and disposes containers; and contracts for the repair, repositioning, and storage of containers. The company leases its container equipment to lessees under long-term, short-term, and finance leases to container shipping lines, freight forwarders, and other transportation companies. It also sells containers primarily to investor groups, and provides management services to those investors, as well as sells used containers. In addition, the company leases railcars consisting of box cars for paper and forest products; covered hoppers for grain, cement, sand, plastic pallets, and other industrial products; general purpose tank cars that are used to transport non-hazardous commodities; gondolas for coal; and general service flat cars. As of December 31, 2014, it had a container fleet comprised 1,175,656 cost equivalent units; and an owned fleet of 2,361 railcars in North America primarily to railroad transport companies. The company was formerly known as Container Applications International, Inc. and changed its name to CAI International, Inc. in February 2007. CAI International, Inc. was founded in 1989 and is headquartered in San Francisco, California.http://www.priceseries.com/trade/CAI-CAI-Intl-Inc-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2019120520200109.html

AXTI AXT Inc gains 21% Jan 9, 2020

AXT, Inc. designs, develops, manufactures, and distributes compound and single element semiconductor substrates. The company manufactures its semiconductor substrates using its proprietary vertical gradient freeze technology. It offers semi-insulating gallium with arsenic (GaAs) substrates, which are used for applications in power amplifiers for wireless devices, and transistors and solar cells for drones. The company also provides semi-conducting GaAs substrates that are used in opto-electronic products, including high brightness LEDs in backlight wireless handsets and LCD TVs, as well as for automotive, signage, display, and lighting applications; and 3-D sensing using vertical cavity surface emitting lasers. In addition, it offers indium with phosphorous substrates used in fiber optic lasers and detectors, passive optical networks (PONs), data center connectivity products, silicon photonics, photonic ICs (PICs), terrestrial solar cells (CPV), lasers, RF amplifiers (military wireless), and infrared motion control and infrared thermal imaging products; and germanium substrates for space and terrestrial photovoltaic, as well as optical applications. Further, the company, through its subsidiaries and joint ventures, manufactures and sells raw materials for gallium, gallium alloys, indium phosphide poly-crystal, germanium, germanium dioxide, high purity arsenic, pyrolytic boron nitride, and boron oxide. AXT, Inc. sells its products through direct sales force in the United States and China, as well as through independent sales representatives and distributors in Europe and other parts of Asia. The company was formerly known as American Xtal Technology, Inc. and changed its name to AXT, Inc. in July 2000. AXT, Inc. was founded in 1986 and is headquartered in Fremont, California.http://www.priceseries.com/trade/AXTI-AXT-Inc-stock-gains-21-percent-a-Trade-Record-by-priceSeries-2019121720200109.html

AUPH Aurinia Pharmaceuticals Inc gains 284% Jan 9, 2020

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, is engaged in the development of a therapeutic drug to treat autoimmune diseases in Canada. The company's lead drug includes Voclosporin, a calcineurin inhibitor for the treatment of lupus nephritis. It has a development and license agreement with 3SBio Inc. for the clinical development, registration, and commercialization of voclosporin in China; and licensing and collaboration agreement with Vifor Pharma for the treatment of lupus and various proteinuric nephrology indications. The company was formerly known as Isotechnika Pharma Inc. and changed its name to Aurinia Pharmaceuticals Inc. in October 2013. Aurinia Pharmaceuticals Inc. was founded in 1993 and is headquartered in Victoria, Canada.http://www.priceseries.com/trade/AUPH-Aurinia-Pharmaceuticals-Inc-stock-gains-284-percent-a-Trade-Record-by-priceSeries-2019111520200109.html

AQXP Aquinox Pharmaceuticals, Inc. gains 71% Jan 3, 2020

Aquinox Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology. The company primarily focuses on anti-inflammatory product candidates targeting SH2-containing inositol-5'-phosphatase 1 (SHIP1) enzyme, a key regulator of a cellular signaling pathway in immune cells. Its lead product candidate is AQX-1125, a small molecule activator of SHIP1 that is in Phase III clinical trials for treatment in interstitial cystitis/bladder pain syndrome, a chronic inflammatory disease of the bladder. The company was founded in 2003 and is headquartered in Vancouver, Canada.http://www.priceseries.com/trade/AQXP-Aquinox-Pharmaceuticals-Inc-stock-gains-71-percent-a-Trade-Record-by-priceSeries-2019120920200103.html

AIMT Aimmune Therapeutics, Inc. gains 16% Jan 9, 2020

Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes product candidates for the treatment of peanut and other food allergies in the United States and Europe. Its lead Characterized Oral Desensitization ImmunoTherapy product candidate is AR101, an investigational biologic for the treatment of patients with peanut allergy. Aimmune Therapeutics, Inc. has strategic collaboration with an affiliate of Nestle Health Science US Holdings, Inc. for the advancement of food allergy therapeutics. The company was formerly known as Allergen Research Corporation and changed its name to Aimmune Therapeutics, Inc. in May 2015. The company was founded in 2011 and is headquartered in Brisbane, California.http://www.priceseries.com/trade/AIMT-Aimmune-Therapeutics-Inc-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2019120320200109.html